These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39258398)

  • 1. Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria.
    Salvaterra Pasquini JP; Queiroz PA; Rodrigues do Amaral PH; da Silva TC; Souza Bonfim Mendonça P; Vandresen F; Carvalho Ceolis JP; de Lima Scodro RB; Caleffi-Ferracioli KR; Cardoso RF; Dias Siqueira VL
    Future Microbiol; 2024; 19(17):1445-1454. PubMed ID: 39258398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic activity of polymyxin B combined with vancomycin against carbapenem-resistant and polymyxin-resistant Acinetobacter baumannii: first in vitro study.
    Shinohara DR; Menegucci TC; Fedrigo NH; Migliorini LB; Carrara-Marroni FE; Maria Dos Anjos M; Cardoso CL; Nishiyama SAB; Tognim MCB
    J Med Microbiol; 2019 Mar; 68(3):309-315. PubMed ID: 30663954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negatively charged nanodiscs for the reduction of toxicity and enhanced efficacy of polymyxin B against Acinetobacter baumannii sepsis.
    Wang P; Xie C; Zhang Y; Li H; Lu Y; Sun L; Hu X; Nie T; Li C; Li G; Lu X; Pang J; Yang X; Yu L; Li X; Wang X; You X
    Acta Biomater; 2024 Aug; 184():323-334. PubMed ID: 38901753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world data on the effects of colistin sulfate and polymyxin B sulfate in the treatment of pneumonia induced by CR-GNB.
    Liu D; Jie F; Ding Y; Qu H; Chen D; Huang J
    J Infect Dev Ctries; 2024 Jul; 18(7):1050-1057. PubMed ID: 39078788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China.
    Wu X; Huang C; Wang H; Ji J; Ying C; Xiao Y
    Drug Des Devel Ther; 2021; 15():2593-2603. PubMed ID: 34168431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
    Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
    J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
    Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
    Razavi Nikoo H; Ardebili A; Mardaneh J
    Microb Drug Resist; 2017 Sep; 23(6):744-756. PubMed ID: 28085571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-targeting, ultrashort lipopeptide acts as an antibiotic adjuvant and sensitizes MDR gram-negative pathogens toward narrow-spectrum antibiotics.
    Panjla A; Kaul G; Shukla M; Akhir A; Tripathi S; Arora A; Chopra S; Verma S
    Biomed Pharmacother; 2024 Jul; 176():116810. PubMed ID: 38823276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel decoy strategy for polymyxin resistance in
    Park J; Kim M; Shin B; Kang M; Yang J; Lee TK; Park W
    Elife; 2021 Jun; 10():. PubMed ID: 34180396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origanum vulgare essential oil: antibacterial activities and synergistic effect with polymyxin B against multidrug-resistant Acinetobacter baumannii.
    Amaral SC; Pruski BB; de Freitas SB; Allend SO; Ferreira MRA; Moreira C; Pereira DIB; Junior ASV; Hartwig DD
    Mol Biol Rep; 2020 Dec; 47(12):9615-9625. PubMed ID: 33190200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent synergy and sustained bactericidal activity of polymyxins combined with Gram-positive only class of antibiotics versus four Gram-negative bacteria.
    Wang Y; Feng J; Yu J; Wen L; Chen L; An H; Xiao W; Zhang B; Feng H; Zhou M; Jiang Z
    Ann Clin Microbiol Antimicrob; 2024 Jul; 23(1):60. PubMed ID: 38965559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenem-polymyxin-resistant
    Sturaro MC; Damaceno NdS; Faccin ID; Silva ON; de Aquino TM; Freire NML; Alcântara MGdS; Monteiro KLC; Rossato L; de Souza GHdA; Simionatto S
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0093024. PubMed ID: 39254296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of intravenous and inhaled polymyxin B treatment in patients with multidrug-resistant gram-negative bacterial pneumonia.
    Ding P; Li H; Nan Y; Liu C; Wang G; Cai H; Yu W
    Int J Antimicrob Agents; 2024 Oct; 64(4):107293. PubMed ID: 39094752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections.
    Menegucci TC; Albiero J; Migliorini LB; Alves JL; Viana GF; Mazucheli J; Carrara-Marroni FE; Cardoso CL; Tognim MC
    Int J Antimicrob Agents; 2016 May; 47(5):380-5. PubMed ID: 27068675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a polymyxin drop test for polymyxin resistance detection among non-fermentative gram-negative rods and enterobacterales resistant to carbapenems.
    Perez LRR; Carniel E; Narvaez GA; Dias CG
    APMIS; 2021 Mar; 129(3):138-142. PubMed ID: 33164263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vitro synergy of polymyxin B-based combinations against polymyxin B -resistant gram-negative bacilli.
    Li Y; Guo S; Li X; Yu Y; Yan B; Tian M; Xu B; Hu H
    Microb Pathog; 2022 May; 166():105517. PubMed ID: 35398467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and safety of polymyxin B in the treatment of carbapenem-resistant Gram-negative bacterial infections: a real-world multicenter study.
    Zhang X; Qi S; Duan X; Han B; Zhang S; Liu S; Wang H; Zhang H; Sun T
    J Transl Med; 2021 Oct; 19(1):431. PubMed ID: 34656132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli.
    Scudeller L; Righi E; Chiamenti M; Bragantini D; Menchinelli G; Cattaneo P; Giske CG; Lodise T; Sanguinetti M; Piddock LJV; Franceschi F; Ellis S; Carrara E; Savoldi A; Tacconelli E
    Int J Antimicrob Agents; 2021 May; 57(5):106344. PubMed ID: 33857539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.